Crossmark

Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers

Crossref DOI link: https://doi.org/10.1007/s40615-020-00853-0

Published Online: 2020-09-08

Published Print: 2021-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sarangarajan, Rangaprasad http://orcid.org/0000-0001-9403-9421
Winn, Robert

Kiebish, Michael A.

Bountra, Chas

Granger, Elder

Narain, Niven R.
License Information

Text and Data Mining valid from 2020-09-08

Version of Record valid from 2020-09-08
More Information

Article History

Received: 2 May 2020

Revised: 5 August 2020

Accepted: 24 August 2020

First Online: 8 September 2020

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below